multiple sclerosis news - Search News

Roche, multiple sclerosis

Hosted on MSN · 6d

US FDA approves injectable version of Roche's multiple sclerosis therapy

The U.S. Food and Drug Administration on Thursday approved Roche's under-the-skin injection to treat patients with multiple sclerosis. The therapy is already approved as an infusion or IV therapy for multiple sclerosis,

News Medical on MSN · 16h

Therapeutic inertia in the treatment of women with multiple sclerosis revealed

A study has revealed significant therapeutic inertia in the treatment of women with multiple sclerosis (MS), highlighting gender disparities that could impact long-term health outcomes for women of childbearing age.

FDA approves Roche’s injectable version of blockbuster multiple sclerosis drug

Patients will be able to get a 10 minute injection of the Roche drug, instead of an hours-long infusion. Novartis already has its own injectable MS drug, Kesimpta.

MarketWatch · 6d

Roche Gets FDA Approval for Multiple-Sclerosis Treatment

Roche Holding's Genentech unit said the Food and Drug Administration approved its twice-yearly, subcutaneous injection treatment for patients with two types of multiple sclerosis. The treatment, called Ocrevus Zunovo,

Medpage Today on MSN23h

Higher Comorbidity Burden in Multiple Sclerosis Tied to Worse Outcomes

"Those with the highest burden of comorbidity had over a 30% increased risk of having disability worsening," Salter said. "In ...

Investor's Business Daily on MSN22h

IBD 50's TG Therapeutics Rises On Five-Year Data For Multiple Sclerosis Drug

TG Therapeutics stock popped Wednesday after the company unveiled promising five-year test results for its multiple sclerosis ...

Multiple Sclerosis News Today1d

ECTRIMS 2024: Mavenclad sustains benefits in relapsing MS

A short course of Mavenclad can provide long-term reductions in disease activity and disability progression in highly active ...

1don MSN

Early treatment significantly reduces long-term disability in children with multiple sclerosis, new study finds

New research presented today at European Committee for Treatment and Research in Multiple Sclerosis 2024 reveals that ...

The American Journal of Managed Care2d

Subcutaneous Ocrelizumab and Hyaluronidase Approved for RMS, PPMS

Ocrelizumab and hyaluronidase is now the first and only twice-yearly subcutaneous injection approved for relapsing multiple ...

News Medical on MSN1d

$1 Million Grant to Fund Research of Nerve Regeneration in Multiple Sclerosis Patients

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...

1don MSN

Ancestry-specific genetic variants linked to multiple sclerosis risk

A study has uncovered novel ancestry-specific genetic variants linked to multiple sclerosis (MS), offering new insights that ...

Does Multiple Sclerosis Protect Against Alzheimer's?

Patients with MS showed half the rate of amyloid pathology compared with people without MS, suggesting a possible protective ...

1don MSN

California’s cap on health care costs is the nation’s strongest. But will patients notice?

Vickie Villegas had to pay $3,000 out-of-pocket every time she was treated for multiple sclerosis, a disease that attacks the ...

BUCKSCO.Today on MSN13h

Local Multiple Sclerosis Advocate Honored With State Citation

Bucks County resident Joseph “Smiley” Terinoni was recently presented with a citation from the Pennsylvania House of ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results